Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

DR Congo delays Covid-19 vaccine rollout

AstraZeneca

DR Congo has received 1.7 million doses of the AstraZeneca vaccine through UN’s shot-sharing mechanism.

Photo credit: AFP

Kinshasa

The Democratic Republic of Congo has put off the start of the vaccination campaign against the coronavirus.

The country was scheduled to rollout Covid-19 vaccination campaign on March 15.

This week several European counties suspended use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford.

On Friday, DRC National Assembly addressed concerns over the vaccine.

“Who will be responsible in the event of serious post-vaccination side effects? Is it the Congolese government, laboratories, doctors, the Covax initiative or who else?” An MP questioned the Minister of Health Dr Eteni Longondo

British pharmaceutical company AstraZeneca issued a statement and said there was "no evidence of an aggravated risk" of a blood clot caused by its vaccine against Covid-19.

DRC had already received 1.7 million doses of AstraZeneca vaccine.

Three groups of people were given priority in the first phase of the roll-out. They include health professionals, social workers, people with comorbidity and people aged over 55.